Trevi Therapeutics, Inc. (TRVI) Earnings
NASDAQ·Healthcare·Biotechnology
$16.07
+1.04%
Mkt Cap $2.45B
EPS — Estimate vs Actual
Mkt Cap
$2.45B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.32
NASDAQ·Healthcare·Biotechnology
$16.07
+1.04%
Mkt Cap $2.45B
Mkt Cap
$2.45B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.32